Achillion Pharmaceuticals Stock Price To Earnings To Growth
Achillion Pharmaceuticals fundamentals help investors to digest information that contributes to Achillion Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Achillion Pink Sheet. The fundamental analysis module provides a way to measure Achillion Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Achillion Pharmaceuticals pink sheet.
Achillion |
Achillion Pharmaceuticals Company Price To Earnings To Growth Analysis
Achillion Pharmaceuticals' PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.
Current Achillion Pharmaceuticals Price To Earnings To Growth | (0.66) X |
Most of Achillion Pharmaceuticals' fundamental indicators, such as Price To Earnings To Growth, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Achillion Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Generally speaking, PEG ratio is a 'quick and dirty' way to measure how the current price of a firm's stock relates to its earnings and growth rate. The main benefit of using PEG ratio is that investors can compare the relative valuations of companies within different industries without analyzing their P/E ratios.
CompetitionBased on the latest financial disclosure, Achillion Pharmaceuticals has a Price To Earnings To Growth of -0.66 times. This is 105.5% lower than that of the Communication Services sector and significantly lower than that of the Advertising Agencies industry. The price to earnings to growth for all United States stocks is 113.5% higher than that of the company.
Achillion Price To Earnings To Growth Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Achillion Pharmaceuticals' direct or indirect competition against its Price To Earnings To Growth to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Achillion Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Achillion Pharmaceuticals by comparing valuation metrics of similar companies.Achillion Pharmaceuticals is currently under evaluation in price to earnings to growth category among its peers.
Achillion Fundamentals
| Return On Equity | -0.0023 | |||
| Return On Asset | -115.43 | |||
| Operating Margin | (586.17) % | |||
| Current Valuation | 6.21 M | |||
| Shares Outstanding | 30 M | |||
| Shares Owned By Insiders | 97.61 % | |||
| Number Of Shares Shorted | 16.38 M | |||
| Price To Earning | (23.49) X | |||
| Price To Book | 4.00 X | |||
| Price To Sales | 710.14 X | |||
| Revenue | 8.7 K | |||
| Gross Profit | 7.87 K | |||
| EBITDA | (43.34 K) | |||
| Net Income | (51 K) | |||
| Cash And Equivalents | 1.44 K | |||
| Total Debt | 61 K | |||
| Debt To Equity | 1.00 % | |||
| Current Ratio | 0.02 X | |||
| Cash Flow From Operations | (39.76 K) | |||
| Short Ratio | 7.89 X | |||
| Earnings Per Share | (0) X | |||
| Price To Earnings To Growth | (0.66) X | |||
| Number Of Employees | 56 | |||
| Beta | 1.59 | |||
| Market Capitalization | 6.18 M | |||
| Total Asset | 464.52 M | |||
| Retained Earnings | (653.45 M) | |||
| Working Capital | 447.93 M | |||
| Current Asset | 462.59 M | |||
| Current Liabilities | 14.66 M | |||
| Z Score | 59.2 |
Pair Trading with Achillion Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Achillion Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Achillion Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Microsoft could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Microsoft when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Microsoft - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Microsoft to buy it.
The correlation of Microsoft is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Microsoft moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Microsoft moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Microsoft can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Consideration for investing in Achillion Pink Sheet
If you are still planning to invest in Achillion Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Achillion Pharmaceuticals' history and understand the potential risks before investing.
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |